Dexmedetomidine Oral Mucosa Patch for Sedation Suppresses Apoptosis in Hippocampus of Normal Rats
1
조회
0
다운로드
9
인용
0
참고문헌
키워드
초록
Purpose: Dexmedetomidine, an α2-adrenergic agonist, provides sedative and analgesic effects without significant respiratory depression. Dexmedetomidine has been suggested to have an antiapoptotic effect in response to various brain insults. We developed an oral mucosa patch using dexmedetomidine for sedation. The effects of the dexmedetomidine oral mucosa patch on cell proliferation and apoptosis in the hippocampus were evaluated. Methods: A hydrogel oral mucosa patch was adhered onto the oral cavity of physiologically normal rats, and was attached for 2 hours, 6 hours, 12 hours, or 24 hours. Plasma dexmedetomidine concentrations were determined by liquid chromatography– electrospray ionization–tandem mass spectrometry–multiple-ion reaction monitoring (LC-ESI-MS/MS-MRM). Cell proliferation in the hippocampus was detected by Ki-67 immunohistochemistry. Caspase-3 immunohistochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining, and Western blotting for Bax and Bcl-2 were performed to detect hippocampal apoptosis. The levels of brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) in the hippocampus were also measured by Western blotting. Results: Plasma dexmedetomidine concentration increased according to the attachment time of the dexmedetomidine oral mucosa patch. Hippocampal cell proliferation did not change due to the dexmedetomidine oral mucosa patch, and the dexmedetomidine oral mucosa patch exerted no significant effect on BDNF or TrkB expression. In contrast, the dexmedetomidine oral mucosa patch exerted an antiapoptotic effect depending on the attachment time of the dexmedetomidine oral mucosa patch. Conclusions: A dexmedetomidine oral mucosa patch can be used as a convenient tool for sedation, and is of therapeutic value due to its antiapoptotic effects under normal conditions.
Abstract
Purpose: Dexmedetomidine, an α2-adrenergic agonist, provides sedative and analgesic effects without significant respiratory depression. Dexmedetomidine has been suggested to have an antiapoptotic effect in response to various brain insults. We developed an oral mucosa patch using dexmedetomidine for sedation. The effects of the dexmedetomidine oral mucosa patch on cell proliferation and apoptosis in the hippocampus were evaluated. Methods: A hydrogel oral mucosa patch was adhered onto the oral cavity of physiologically normal rats, and was attached for 2 hours, 6 hours, 12 hours, or 24 hours. Plasma dexmedetomidine concentrations were determined by liquid chromatography– electrospray ionization–tandem mass spectrometry–multiple-ion reaction monitoring (LC-ESI-MS/MS-MRM). Cell proliferation in the hippocampus was detected by Ki-67 immunohistochemistry. Caspase-3 immunohistochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining, and Western blotting for Bax and Bcl-2 were performed to detect hippocampal apoptosis. The levels of brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) in the hippocampus were also measured by Western blotting. Results: Plasma dexmedetomidine concentration increased according to the attachment time of the dexmedetomidine oral mucosa patch. Hippocampal cell proliferation did not change due to the dexmedetomidine oral mucosa patch, and the dexmedetomidine oral mucosa patch exerted no significant effect on BDNF or TrkB expression. In contrast, the dexmedetomidine oral mucosa patch exerted an antiapoptotic effect depending on the attachment time of the dexmedetomidine oral mucosa patch. Conclusions: A dexmedetomidine oral mucosa patch can be used as a convenient tool for sedation, and is of therapeutic value due to its antiapoptotic effects under normal conditions.
참고문헌 (30)
- Paris A, "Dexmedetomidine in anaesthesia", Curr Opin Anaesthesiol, 18, pp.412~418 (2005)
- Jevtovic-Todorovic V, "Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits", J Neurosci, 23, pp.876~882 (2003)
- Duan X, "Dexmedetomidine provides neuroprotection : impact on ketamine-induced neuroapoptosis in the developing rat brain", Acta Anaesthesiol Scand, 58, pp.1121~1126 (2014)
- Li Y, "Dexmedetomidine reduces isoflurane-induced neuroapoptosis partly by preserving PI3K", Akt pathway in the hippocampus of neonatal rats, 2014, pp.9, e93639~
- Afonso J, "Dexmedetomidine : current role in anesthesia and intensive care", Rev Bras Anestesiol, 62, pp.118~133 (2012)
- Engelhard K, "The effect of the α2-agonist dexmedetomidine and the Nmethyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats", Anesth Analg, 96, pp.524~531 (2003)
- Dahmani S, "Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an α2-adrenoceptor-independent mechanism : evidence for the involvement of imidazoline I1 receptors", Anesthesiology, 108, pp.457~466 (2008)
- Sanders RD, "Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats", Anesthesiology, 110, pp.1077~1085 (2009)
- Sanders RD, "Dexmedetomidine provides cortical neuroprotection : impact on anaesthetic-induced neuroapoptosis in the rat developing brain", Acta Anaesthesiol Scand, 54, pp.710~716 (2010)
- Kim SE, "Dexmedetomidine promotes the recovery of the field excitatory postsynaptic potentials(fEPSPs)in rat hippocampal slices exposed to oxygen-glucose deprivation", Neurosci Lett, 631, pp.91~96 (2016)
- Hwang L, "Dexmedetomidine ameliorates intracerebral hemorrhage-induced memory impairment by inhibiting apoptosis and enhancing brain-derived neurotrophic factor expression in the rat hippocampus", Int J Mol Med, 31, pp.1047~1056 (2013)
- Choi IY, "Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils", Exp Ther Med, 13, pp.107~116 (2017)
- Sung YH, "Depression-like state in maternal rats induced by repeated separation of pups is accompanied by a decrease of cell proliferation and an increase of apoptosis in the hippocampus", Neurosci Lett, 470, pp.86~90 (2010)
- 이성민, "Music application alleviates short-term memory impairments through increasing cell proliferation in the hippocampus of valproic acid-induced autistic rat pups", Journal of exercise rehabilitation, 12(3), pp.148~155 (2016), 한국운동재활학회
- 박제훈, "Pentoxifylline Alleviates Perinatal Hypoxic-Ischemia-Induced Short-term Memory Impairment by Suppressing Apoptosis in the Hippocampus of Rat Pups", International Neurourology Journal, 20(2), pp.107~113 (2016), 대한배뇨장애요실금학회
- 노주환, "Treadmill exercise ameliorates intracerebral hemorrhage-induced depression in rats", Journal of exercise rehabilitation, 12(4), pp.299~307 (2016), 한국운동재활학회
- 백성수, "Treadmill exercise ameliorates symptoms of Alzheimer disease through suppressing microglial activation-induced apoptosis in rats", Journal of exercise rehabilitation, 12(6), pp.526~534 (2016), 한국운동재활학회
- 한진희, "Dexmedetomidine, α2-adrenoceptor agonist, does not induce apoptosis in the brachial plexus of rats", Animal Cells and Systems, 18(6), pp.407~415 (2014), 한국통합생물학회[DOI]
- Gould E, "Learning enhances adult neurogenesis in the hippocampal formation", Nat Neurosci, 2, pp.260~265 (1999)
- Kee N, "The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis", J Neurosci Methods, 115, pp.97~105 (2002)
- Li Y, "Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats", Stroke, 26, pp.1252~1257 (1995)
- Reed CJ., "Apoptosis and cancer: strategies for integrating programmed cell death", Semin Hematol, 37(4 Suppl), pp.9~16 (2000)
- Benchoua A, "Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia", J Cereb Blood Flow Metab, 24, pp.1272~1279 (2004)
- Suh HJ, "Neuroprotective effects of tamsulosin on intracerebral hemorrhage", Neural Regen Res, 6, pp.2505~2510 (2011)
- Kuwana T, "Bcl-2-family proteins and the role of mitochondria in apoptosis", Curr Opin Cell Biol, 15, pp.691~699 (2003)
- Upadhyay D, "Particulate matter induces alveolar epithelial cell DNA damage and apoptosis : role of free radicals and the mitochondria", Am J Respir Cell Mol Biol, 29, pp.180~187 (2003)
- Gomez-Pinilla F, "A"deficient environment"in prenatal life may compromise systems important for cognitive function by affecting BDNF in the hippocampus", Exp Neurol, 192, pp.235~243 (2005)
- Minichiello L, "TrkB signalling pathways in LTP and learning", Nat Rev Neurosci, 10, pp.850~860 (2009)
- 황동섭, "Treadmill Exercise Improves Memory Function Depending on Circadian Rhythm Changes in Mice", International Neurourology Journal, 20, pp.141~149 (2016), 대한배뇨장애요실금학회
- 이삼준, "Postnatal Treadmill Exercise Alleviates Prenatal Stress-Induced Anxiety in Offspring Rats by Enhancing Cell Proliferation Through 5-Hydroxytryptamine 1A Receptor Activation", International Neurourology Journal, 20, pp.57~64 (2016), 대한배뇨장애요실금학회